Collagen is the main structural protein in skin, tendon, bone and cartilage. Oral collagen peptides are hydrolysed into di- and tri-peptides and free amino acids that are absorbed and, in small amounts, can reach connective tissue. Human evidence is most defensible for modest improvements in skin elasticity/hydration and for adjunct use in tendon/ligament rehabilitation when paired with loading. As a general-purpose 'anti-aging' or joint-fixing supplement, claims outrun evidence.
Collagen peptides have a real but narrow evidence base: modest skin outcomes at 2.5–10 g/day and possible tendon/ligament benefits at 15 g/day taken ~1 hour before loading. For general protein needs, whey or mixed dietary protein is superior — collagen is low in leucine and an incomplete protein. Most 'beauty from within' and joint-cure claims are overstated.
Each row grades the claimed effect by strength of human evidence, not mechanism or marketing.
Low-risk with a narrow, defensible use case in skin and connective-tissue adaptation. Not a first-line recommendation for joint disease or general protein needs.
Frequently marketed as beauty-from-within, anti-aging, joint-healing and gut-repair — these claims routinely exceed the trial evidence.
The literature lacks long-duration, independently funded RCTs with clinical rather than cosmetic endpoints, and head-to-head comparisons against equivalent-protein whey or mixed protein.
Oral collagen is digested into peptides and amino acids — it does not travel intact to skin or joints. The benefit, where it exists, is indirect and modest.
Hydrolysed collagen peptides (2–10 kDa) absorb better than intact gelatin; glycine/proline/hydroxyproline-rich di- and tri-peptides can reach plasma.
For tendon/ligament outcomes, timing matters: protocols take 15 g with vitamin C 30–60 min before loading to coincide with collagen synthesis.
Collagen is an incomplete protein with low leucine and no tryptophan — treat it as a functional supplement, not a protein source.
Marine, bovine and porcine sources behave similarly in trials; 'marine' premium pricing is not clearly justified.
Mechanism is not outcome. Each mechanism is labelled by how far it has been validated in humans.
Hydrolysed collagen yields di- and tri-peptides (notably Pro-Hyp and Hyp-Gly) that survive digestion and appear in plasma, potentially signalling to fibroblasts and tenocytes.
In vitro, collagen-derived peptides stimulate fibroblast proliferation and extracellular matrix synthesis. Whether plasma concentrations from typical doses are sufficient to drive clinical effects is less certain.
Collagen is ~33% glycine. Additional glycine may support connective-tissue synthesis and has separate sleep-related effects, but is not unique to collagen as a source.
Generally well tolerated in short-term trials. No significant toxicity signal at standard doses.
This page is educational and not medical advice. Collagen is a protein and contributes to total daily protein intake. Discuss supplementation with a clinician if you have kidney disease, pregnancy considerations, or source allergies.
A small, curated set — not a literature dump. Each reference comes with a single-line takeaway.
2.5 g/day specific collagen peptides over 8 weeks in women aged 45–65 improved skin elasticity and hydration versus placebo. Industry-funded; modest effect size.
Pooled analysis of 19 short RCTs found small but consistent improvements in hydration and elasticity. Heterogeneity and industry funding are limitations.
15 g gelatin + 50 mg vitamin C taken 1 hour before jump training doubled a marker of collagen synthesis versus placebo in young men. Surrogate endpoint, small sample.
10 g/day collagen hydrolysate for 24 weeks reduced activity-related knee pain in young athletes. Industry-funded; symptom endpoint, not structural.